Pfizer facing FCPA probes into China operations


Pharmaceutical firm Pfizer announced in a recent regulatory filing that it has received requests from the Department of Justice and the Securities and Exchange Commission regarding the company’s operations in China.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.